本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

79.57
+0.19000.24%
成交量:24.20萬
成交額:1,930.66萬
市值:62.08億
市盈率:80.37
高:80.15
開:79.36
低:79.22
收:79.38
52周最高:82.94
52周最低:32.89
股本:7,802.40萬
流通股本:4,019.47萬
量比:0.65
換手率:0.60%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:9.49
市盈率(LYR):106.09

資料載入中...

2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/14

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities